SEC 13F Intelligence

Mwg Caph Ltd / PRME

Mwg Caph Ltd’s Prime Medicine Inc Position

Does Mwg Caph Ltd own Prime Medicine Inc (PRME)? Yes1.79M shares worth $6M (+8.59% of its 13F portfolio) as of Q4 2025.

Position Value
$6M
Q4 2025
Shares
1.79M
% of Portfolio
+8.59%
Quarters Held
1
currently held

Position History PRME

Reported value by quarter
Q4 ’25: $6MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20251.79M$6M+8.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mwg Caph Ltd’s full portfolio or all institutional holders of PRME.